HAUS1 and central nervous system cancer: Furthermore, to assess whether HAUS1 could serve as a prognostic marker for glioma, we performed Kaplan–Meier survival analysis to compare the PFI, DSS, and OS of patients with glioma between the low- and high-HAUS1-expression groups.